Cost-effectiveness of intravenous vedolizumab vs subcutaneous adalimumab for moderately to severely active ulcerative colitis

by Carter, J.A, Diakite, I., Schultz, B.G, Snedecor, S.J, Turpin, R.
Published 2021

Efficacy of Infliximab Dose Escalation in Patients with Refractory Immunotherapy-Related Colitis: A Case Series

by Faleck, D.M, Harris, J.P, Postow, M.A
Published 2022

Outcomes and Long-Term Effects of COVID-19 in Patients with Inflammatory Bowel Diseases - A Danish Prospective Population-Based Cohort Study with Individual-Level Data

by Attauabi, M., Burisch, J., Dahlerup, J.F, Eraslan, S., Glerup, H., Haderslev, K.V, Hansen, M.R, Jensen, M.D, Jess, T., Kiszka-Kanowitz, M., Larsen, L., Lødrup, A.B, Molazahi, A., Neumann, A., Oppfeldt, A.M, Pedersen, N., Poulsen, A., Prahm, A.P, Seidelin, J.B, Theede, K., Vester-Andersen, M.K
Published 2022

Ulcerative colitis as a possible sequela of COVID-19 Infection: The endless story

by El Kassas, M., Elbadry, M., Medhat, M.A, Zaky, S.
Published 2022

Effect of Ramadan intermittent fasting on inflammatory markers, disease severity, depression, and quality of life in patients with inflammatory bowel diseases: A prospective cohort...

by Abd El Aaty, W., Badary, H.A, Bahaa, A., Basiony, A., Dawoud, I., Essam, M., Farrag, A., Kamel, S., Lithy, R.M, Negm, M., Sakr, M., Shamkh, M., Shehab, H.
Published 2022